Sharing very useful slides from professor Orozco today on the webinar "Retos y Oportunidades para la Producción farmacéutica en Colombia" phmovement.org/node/3597

An excellent, frank and concrete presentation by the hosts, Asinfar, the association of local private pharmaceutical producers.

Executive President, Carlos Francisco Fernandez: "We export history, we import dependence".

(2/2)Dr.
Rossi:
- Free trade leaves us immensely vulnerable to pandemics. It also generated a pharmaceutical industry protected by intellectual property protection.
- In the midst of global turbulence, opportunity for countries and actors to generate new agreements that benefit us as a region.

(1/2) Dr. Francisco Rossi, INVIMA's director:
- World War II and Covid: precedents for drug hoarding
- Local pharmaceutical production is strategic
- Invitation to think of regional market with converging standards
- Pharmaceutical industries in the region are mature

Minister of Health of Colombia:
- Strengthening of drug production capacities.
- Design, development and production of strategic public health medicines with Universidad de Antioquia.
- Projects for local production of vaccines and biologics.

#Biologics
#Local #alliances
#Medicines #production

Dr. Emilio Sardi, President of the Board of Directors of Asinfar:
- Strengthening of the Latin American pharmaceutical chain
- Regional integration
- Industrial development as social development
- From diagnosis of the situation to commitment

#ASINFAR
#ALIFAR

How fortunate to be in this forum dedicated to strengthening local capacities in the pharmaceutical production region. Identifying possibilities for connecting approaches to promote public health and development with equity.
#Access to #Medicines
#Local #pharmaceutical #production
#HumanRights

Every day more countries are championing a new way forward—where all nations contribute, decide, and benefit.
It’s time to reimagine how we fund global solutions—for health, climate, peace, and development—and ensure that international cooperation truly serves the common good
#globalpublicinvestment

Congratulations!!!

President Trump on Monday signed an executive order designed to lower regulatory hurdles and make it faster for drug companies to manufacture their products in the U.S.

www.instagram.com/reel/DF2wf0t...

#saveforeignaid
#standwithusaid

*breaking* we are blocking traffic, demanding an end to Rubio’s illegal stop-work order that is killing people with AIDS.

"Hennessy nos habla de la necesidad de un nuevo humanismo, de un religare no religioso sino humano, que propenda por la desaceleración de los actuales estilos de vida a los que nos ha llevado una visión excesivamente racionalista y mecanicista." P Bonnett
😍🌱🌎
www.elespectador.com/opinion/colu...

Carolina Gómez, del CP d medicamentos, Info y Poder (UN) visibilizando la diferencia CLAVE entre mecanismos abreviados d aprobación d medicamentos, q favorece entrada de competidores de 💊 conocidos, y los mecanismos acelerados, q favorecen la entrada d meds "innovadores" con escasa evidencia clínica

Diversas visiones expresadas en Simposio sobre evaluación de nuevos medicamentos.

Cae velo de intereses de mercado detrás de "priorizar enfoque en el paciente". Hasta ahora excelentes presentaciones de gremio profesional farmacéutico de Bogotá, agencias sanitarias de Colombia y Cuba y Carlos Durán

A federal program kills hundreds of thousands of wild animals a year. Documents obtained by NPR show that many of those animals were killed in places where no wildlife damage was reported.

Nearly 60% of the experts who reviewed manuscripts for four top medical journals received at least one payment from industry during a recent three-year period.